Traders Bet on IonQ Micron Anduril as Potential Next US Government Stake Targets Monte Rosa Therapeutics GLUE Q1 2026 Earnings EPS Miss Highlights Ongoing ClinicalStage Costs Stock Gains Modestly Endurance Technologies IPO Opens Key Details and Market Context